产量(工程)
立体选择性
化学
敌手
对抗
加压素拮抗剂
氯化物
立体化学
加压素
药物化学
受体
材料科学
有机化学
内科学
生物化学
医学
冶金
催化作用
作者
Hariharan Venkatesan,Matthew C. Davis,Yeşim Altaş,James P. Snyder,Dennis C. Liotta
摘要
SR 121463 A, 1, is a promising nonpeptide prototype for potent and selective antagonism of the vasopressin V2 receptor subtype and, thus, a candidate for control of the clinically debilitating condition of hyponatremia and its associated syndromes. In the present work, we present a novel and stereoselective synthesis that stems from the preparation of three key intermediates: the substituted benzenesulfonyl chloride 2, the N-protected oxindole 3, and protected dibromide 4. The synthesis of 1 has been achieved in good overall yield, each step proceeding in greater than 80% yield. In addition, intermediate 2 and the syn isomer of 1 were prepared with complete control of stereochemistry. The latter reduction appears to proceed by lithium cation mediated chelation control. Molecular mechanics calculations with the MM3* and MMFF force fields underscore geometric and energetic aspects of the reaction.
科研通智能强力驱动
Strongly Powered by AbleSci AI